New cell vaccine aims to halt multiple sclerosis progression
NCT ID NCT07020715
First seen Jan 11, 2026 · Last updated Jun 11, 2026 · Updated 25 times
Summary
This early-phase trial tests a personalized treatment for people with progressive multiple sclerosis (MS). Doctors take a patient's own immune cells, treat them with vitamin D3 and myelin proteins, and inject them back to 're-train' the immune system to stop attacking nerves. The goal is to slow disability progression and monitor safety in 14 participants over about two years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Germans Trias i Pujol Hospital (HUGTiP)
Badalona, 08916, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
-
Universitair Ziekenhuis Antwerpen (UZA)
Edegem, 2650, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.